-transparent.png){kind=logo}
A pair of rat anti-mouse CD4 monoclonal antibodies (mAb) have been selected which bind to different epitopes of the molecule. Both the mAb are rat IgG2b and show clear synergistic activity in complement lysis in vitro. When injected together in vivo, they exhibit an improved immunosuppressive effect, compared to each antibody alone, on allogeneic graft rejection, humoral responses and on tolerance induction. Limiting dilution analysis indicates that the in vivo depletion of interleukin 2-producing cells is improved using both mAb by 2-3-fold over that obtained with the individual antibodies. As little as 60 ng per mouse of the CD4 antibody pair was sufficient to allow the induction of tolerance to human gamma-globulin, even without elimination of the CD4+ cells. The results suggest that appropriate antibody pairs may be good candidates for effective immunosuppressive serotherapy in man.
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
August 1990,
Transplantation proceedings,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
January 1998,
Novartis Foundation symposium,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
November 1971,
Nature,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
February 1991,
Transplantation proceedings,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
September 1992,
Transplantation,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
July 1991,
Immunology letters,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
January 1986,
Nature,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
July 1993,
The American journal of the medical sciences,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
October 1990,
Transplantation proceedings,
S Qin, and
S Cobbold, and
H Tighe, and
R Benjamin, and
H Waldmann
February 1991,
Transplantation proceedings,
